Gurit Holding Valuation

Is GURN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GURN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GURN (CHF10.96) is trading below our estimate of fair value (CHF32.88)

Significantly Below Fair Value: GURN is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GURN?

Key metric: As GURN is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GURN. This is calculated by dividing GURN's market cap by their current revenue.
What is GURN's PS Ratio?
PS Ratio0.1x
SalesCHF 428.71m
Market CapCHF 52.09m

Price to Sales Ratio vs Peers

How does GURN's PS Ratio compare to its peers?

The above table shows the PS ratio for GURN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
EVE Evolva Holding
1.8xn/aCHF 7.3m
CLN Clariant
0.9x4.3%CHF 3.6b
STLN Swiss Steel Holding
0.03xn/aCHF 65.6m
EMSN EMS-CHEMIE HOLDING
6.9x5.0%CHF 14.7b
GURN Gurit Holding
0.1x3.1%CHF 52.1m

Price-To-Sales vs Peers: GURN is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (2.4x).


Price to Sales Ratio vs Industry

How does GURN's PS Ratio compare vs other companies in the European Chemicals Industry?

24 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.0x5.0%
GURN Gurit Holding
0.1x3.1%US$58.62m
GURN 0.1xIndustry Avg. 1.0xNo. of Companies25PS012345+
24 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.0x8.6%
GURN Gurit Holding
0.1x88.7%US$58.62m
No more companies

Price-To-Sales vs Industry: GURN is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is GURN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GURN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: GURN is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GURN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 10.96
CHF 33.33
+204.1%
28.3%CHF 40.00CHF 20.00n/a3
Nov ’25CHF 19.40
CHF 44.67
+130.2%
14.8%CHF 54.00CHF 40.00n/a3
Oct ’25CHF 26.45
CHF 54.67
+106.7%
22.4%CHF 70.00CHF 40.00n/a3
Sep ’25CHF 33.85
CHF 54.67
+61.5%
22.4%CHF 70.00CHF 40.00n/a3
Aug ’25CHF 43.85
CHF 75.00
+71.0%
14.4%CHF 90.00CHF 65.00n/a3
Jul ’25CHF 54.00
CHF 81.25
+50.5%
17.6%CHF 100.00CHF 65.00n/a4
Jun ’25CHF 59.70
CHF 87.80
+47.1%
13.4%CHF 100.00CHF 70.00n/a5
May ’25CHF 59.00
CHF 87.80
+48.8%
13.4%CHF 100.00CHF 70.00n/a5
Apr ’25CHF 66.40
CHF 86.83
+30.8%
12.0%CHF 100.00CHF 75.00n/a6
Mar ’25CHF 67.90
CHF 86.83
+27.9%
12.0%CHF 100.00CHF 75.00n/a6
Feb ’25CHF 74.50
CHF 88.00
+18.1%
10.7%CHF 100.00CHF 77.00n/a6
Jan ’25CHF 81.60
CHF 91.50
+12.1%
10.2%CHF 100.00CHF 77.00n/a6
Dec ’24CHF 72.60
CHF 91.50
+26.0%
10.2%CHF 100.00CHF 77.00n/a6
Nov ’24CHF 70.60
CHF 91.50
+29.6%
10.2%CHF 100.00CHF 77.00CHF 19.406
Oct ’24CHF 92.90
CHF 102.83
+10.7%
21.8%CHF 150.00CHF 80.00CHF 26.456
Sep ’24CHF 87.90
CHF 102.57
+16.7%
20.3%CHF 150.00CHF 80.00CHF 33.857
Aug ’24CHF 93.40
CHF 101.00
+8.1%
21.0%CHF 150.00CHF 80.00CHF 43.857
Jul ’24CHF 83.30
CHF 101.17
+21.4%
22.7%CHF 150.00CHF 80.00CHF 54.006
Jun ’24CHF 83.20
CHF 101.17
+21.6%
22.7%CHF 150.00CHF 80.00CHF 59.706
May ’24CHF 90.10
CHF 101.17
+12.3%
22.7%CHF 150.00CHF 80.00CHF 59.006
Apr ’24CHF 82.80
CHF 102.43
+23.7%
21.0%CHF 150.00CHF 80.00CHF 66.407
Mar ’24CHF 99.80
CHF 111.00
+11.2%
15.9%CHF 150.00CHF 96.00CHF 67.907
Feb ’24CHF 97.20
CHF 112.29
+15.5%
15.2%CHF 150.00CHF 96.00CHF 74.507
Jan ’24CHF 90.00
CHF 112.43
+24.9%
15.1%CHF 150.00CHF 97.00CHF 81.607
Dec ’23CHF 98.20
CHF 114.83
+16.9%
14.9%CHF 150.00CHF 97.00CHF 72.606
Nov ’23CHF 89.40
CHF 114.83
+28.4%
14.9%CHF 150.00CHF 97.00CHF 70.606

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies